Mesenchymal stromal cell apoptosis is required for their therapeutic function SHM Pang, J D’Rozario, S Mendonca, T Bhuvan, NL Payne, D Zheng, ... Nature communications 12 (1), 6495, 2021 | 132 | 2021 |
Biological considerations in scaling up therapeutic cell manufacturing DS Cherian, T Bhuvan, L Meagher, TSP Heng Frontiers in Pharmacology 11, 654, 2020 | 56 | 2020 |
Secondary lymphoid organs in mesenchymal stromal cell therapy: more than just a filter D Zheng, T Bhuvan, NL Payne, TSP Heng Frontiers in Immunology 13, 892443, 2022 | 6 | 2022 |
Mesenchymal stromal cell apoptosis is required for their therapeutic function. Nat Commun. 2021; 12 (1): 6495 SHM Pang, J D’Rozario, S Mendonca, T Bhuvan, NL Payne, D Zheng | 6 | |
Mesenchymal Stem/Stromal Cells: ROUTE-DEPENDENT MECHANISMS OF MESENCHYMAL STROMAL CELL THERAPY D Zheng, T Bhuvan, N Payne, T Heng Cytotherapy 25 (6), S60, 2023 | | 2023 |
The short chain fatty acid butyrate prevents intracellular replication of Legionella by regulating cysteine levels in macrophages G Abraham, A Swaminathan, C Barlow, T Nguyen, T Bhuvan, T Heng, ... | | 2021 |
Immunometabolic changes in resident macrophages underlie msc therapeutic effects S Pang, T Bhuvan, D Zheng, S Mendonca, J D’Rozario, D Powell, T Heng Cytotherapy 23 (5), S63-S64, 2021 | | 2021 |
Is mesenchymal stromal cell apoptosis necessary for their immunomodulatory capacity? S Pang, J D'Rozario, G Wallis, A Hisana, T Bhuvan, N Payne, D Powell, ... Cytotherapy 22 (5), S87, 2020 | | 2020 |
Investigating the role of apoptosis and tissue macrophages in mesenchymal stromal cell treatment of inflammatory lung diseases T BHUVAN Monash University, 0 | | |